Target
Mu-type opioid receptor
Ligand
BDBM239918
Substrate
n/a
Meas. Tech.
Binding Assay
Temperature
298.15±n/a K
Ki
45±n/a nM
Comments
extracted
Citation
 Nolte, BSchröder, WLinz, KEnglberger, WSchick, HGraubaum, HBraun, BOzegowski, SBálint, JSonnenschein, H Substituted 4-aminocyclohexane derivatives US Patent  US9403767 Publication Date 8/2/2016 
Target
Name:
Mu-type opioid receptor
Synonyms:
M-OR-1 | MOP | MOR-1 | MOR1 | MUOR1 | Mu Opioid Receptor | Mu opiate receptor | OPIATE Mu | OPRM1 | OPRM_HUMAN | hMOP | mu-type opioid receptor isoform MOR-1
Type:
G Protein-Coupled Receptor (GPCR)
Mol. Mass.:
44789.51
Organism:
Homo sapiens (Human)
Description:
P35372
Residue:
400
Sequence:
MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP
  
Inhibitor
Name:
BDBM239918
Synonyms:
US9403767, 92 | US9403767, 93
Type:
Small organic molecule
Emp. Form.:
C26H32N4O
Mol. Mass.:
416.5585
SMILES:
CN(C)C1(CCC(CC1)(N(C)C(=O)c1ccn(C)n1)c1ccccc1)c1ccccc1 |(6.92,4.5,;8.39,4.02,;9.53,5.05,;8.71,2.51,;9.53,1.21,;8.8,-.15,;7.26,-.21,;6.45,1.1,;7.17,2.46,;7.26,-1.75,;6.64,-3.15,;8.6,-2.52,;9.93,-1.75,;8.6,-4.06,;7.35,-4.96,;7.83,-6.43,;9.37,-6.43,;10.27,-7.67,;9.84,-4.96,;5.99,-1.07,;6.09,-2.6,;4.82,-3.46,;3.43,-2.79,;3.33,-1.25,;4.6,-.39,;10.14,3.09,;10.35,4.62,;11.78,5.19,;12.99,4.24,;12.78,2.72,;11.35,2.14,)|
Structure:
Search PDB for entries with ligand similarity: